P-选择素在阿霉素诱导的损伤心肌细胞和心衰组织中的表达

林冉 王琰 胥良 杨少华 米梦雅 马小博 闫灏 郭志坤 赵育洁

解剖学报 ›› 2026, Vol. 57 ›› Issue (4) : 467-474.

PDF(1257 KB)
欢迎访问《解剖学报》官方网站!今天是 English
PDF(1257 KB)
解剖学报 ›› 2026, Vol. 57 ›› Issue (4) : 467-474. DOI: 10.16098/j.issn.0529-1356.2026.04.010
组织学胚胎学发育生物学

P-选择素在阿霉素诱导的损伤心肌细胞和心衰组织中的表达

  • 林冉1,2,3王琰2胥良2杨少华2米梦雅1马小博1闫灏1郭志坤1赵育洁2,3*

作者信息 +

Expression of P-selectin in doxorubicin-induced injured cardiomyocytes and heart failure tissue

  • LIN Ran1,2,3, WANG Yan2, XU Liang2, YANG Shao-hua2, MI Meng-ya1, MA Xiao-bo1, YAN Hao1, GUO Zhi-kun1, ZHAO Yu-jie2,3*
Author information +
文章历史 +

摘要

目的 探讨P-选择素(CD62P)在阿霉素(DOX)诱导的人心肌细胞系 AC16 和人心力衰竭心房肌组织中的表达变化。方法体外培养 AC16,通过不同浓度盐酸阿霉素(1、5、15 μmol//L )处理构建不同程度心肌损伤细胞模型。实验设置对照组(Ctrl)和损伤模型组(IM),分为轻度(IM-Mi)、中度(IM-Mo)、重度(IM-S)组。采用免疫荧光染色鉴定 AC16 细胞表型,CCK-8 法检测 AC16 细胞增殖活性,Western blotting及免疫组织化学染色分别检测 AC16 细胞系和人心衰组织样本中 CD62P 蛋白表达,酶联免疫吸附法测定 DOX 诱导的 AC16 细胞上清和心衰患者血清中 CD62P 的表达水平。结果CD62P 在 AC16 细胞系中随 DOX 浓度升高,损伤程度加重,表达水平升高(P<0.05),呈现剂量依赖性升高趋势。人心衰组织中CD62P阳性率显著高于对照组,且随心衰程度加重表达水平升高(P<0.05),CD62P 血清检测结果与组织结果表达趋势一致。结论 CD62P 在局部组织和外周血清的表达水平与心肌损伤程度成正相关,提示其无论外周还是局部组织的表达水平均可作为评估心衰进展的潜在生物标志物。

Abstract

Objective To investigate the expression changes of P-selectin(CD62P)in the doxorubicin (DOX)induced damaged cardiomyocyte line AC16 and atrial myocardial tissue from patients with heart failure(HF). Methods The AC16 cardiomyocyte line was cultured in vitro, and cardiomyocyte injury models with different degrees of damage were established using DOX at concentrations of 1μmol/L, 5μmol/L, and 15μmol/L. The experiment included control group (Ctrl) and myocardial injury model group (IM), which was further divided into mild (IM-Mi), moderate (IM-Mo), and severe (IM-S) subgroups. Immunofluorescence staining (IF) was used to identify the phenotype of AC16 cells, and the CCK-8 assay was employed to detect the proliferative activity of AC16 cells. Western blotting and immunohistochemical (IHC)staining were respectively used to determine the protein expression of CD62P in the AC16 cell line and human HF tissue samples. Additionally, ELISA was conducted to measure the expression levels of CD62P in the supernatant of AC16 cells with different degrees of DOX-induced damage and in the serum of patients with HF. Results In the AC16 cell line, the expression level of CD62P increased with the elevation of DOX concentration (P<0.05), showing a dose-dependent upward trend. The positive rate of CD62P in the human HF group was significantly higher than that in the control group; Moreover, the expression level of CD62P increased as the severity of HF worsened (P<0.05). The detection result of CD62P in serum were consistent with the expression trend of CD62P in tissue. Conclusion The expression levels of CD62P in local tissues and peripheral serum are positively correlated with the degree of myocardial injury, suggesting that CD62P may serve as a potential biomarker for evaluating the progression of heart failure.

关键词

阿霉素 / 心肌细胞系 / 心衰组织 / P-选择素 / 免疫印迹法 /

Key words

Doxorubicin / Cardiomyocyte cell line / Heart failure tissue / P-selectin;Western blotting / Human

引用本文

导出引用
林冉 王琰 胥良 杨少华 米梦雅 马小博 闫灏 郭志坤 赵育洁. P-选择素在阿霉素诱导的损伤心肌细胞和心衰组织中的表达[J]. 解剖学报. 2026, 57(4): 467-474 https://doi.org/10.16098/j.issn.0529-1356.2026.04.010
LIN Ran , WANG Yan , XU Liang , YANG Shao-hua , MI Meng-ya , MA Xiao-bo , YAN Hao , GUO Zhi-kun , ZHAO Yu-jie.
Expression of P-selectin in doxorubicin-induced injured cardiomyocytes and heart failure tissue
[J]. Acta Anatomica Sinica. 2026, 57(4): 467-474 https://doi.org/10.16098/j.issn.0529-1356.2026.04.010
中图分类号: R329    R542.2   

参考文献

[1] Zhang ShY, Han YL, Xu DL. Chinese guidelines for the diagnosis and treatment of heart failure 2024 [J]. Chinese Journal Cardiology, 2024, 52(3): 235-275. (in Chinese)
 张抒杨, 韩雅玲, 许顶立. 中国心力衰竭诊断和治疗指南2024 [J]. 中华心血管杂志, 2024, 52(3): 235-275.
[2] Hu SS. Heart failure in China: epidemiology and current management [J]. J Geriatr Cardiol, 2024, 21(6): 631-641.
[3] Zhang Y, Ma Z, Liu Q, et al. Clinical significance of PAC-1, CD62P and Platelet-leukocyte aggregates in acute ischemic stroke [J]. Bull Exp Biol Med, 2022, 172(5): 543-548.
[4] Hameed A, Rubab Z, Rizvi SKA, et al. Levels of platelet-derived microparticles and soluble p-selectin in patients of acute myocardial infarction (case control study) [J]. Pak Med Assoc, 2017, 67(7): 998-1003.
[5] Wysokinski WE, Cohoon KP, Melduni RM, et al. Association between p-selectin levels and left atrial blood stasis in patients with nonvalvular atrial fibrillation [J]. Thromb Res, 2018, 172: 4-8.
[6] Kanagala P, Arnold JR, Khan JN, et al. Plasma p-selectin is a predictor of mortality in heart failure with preserved ejection fraction [J]. ESC Heart Fail, 2021, 8(3): 2328-2333.
[7] Irene C, Anirban C, Jeetesh P, et al. Soluble, platelet-bound and total p-selectin as indices of platelet activation in congestive heart failure [J]. Ann Med, 2009, 41: 45-51.
[8] Wang Y, Zhao YJ, Guo ZhK, et al. Effects of cd73 on proliferation and function of rat cardiomyocytes in vitro [J]. Acta Anatomica Sinica, 2022, 53(1): 28-34. (in Chinese) 
王琰, 赵育洁, 郭志坤, 等. CD73对体外大鼠心肌细胞增殖和功能的影响 [J]. 解剖学报, 2022, 53(1): 28-34.
[9] Blann AD, Nadar SK, Lip GYH. The adhesion molecule P-selectin and cardiovascular disease [J]. Eur Heart J, 2003, 24(24): 2166-2179.
[10] Kral-Pointner JB, Haider P, Szabo PL, et al. Reduced monocyte and neutrophil infiltration and activation by P-selectin/CD62p inhibition enhances thrombus resolution in mice [J]. Arterioscler Thromb Vasc Biol, 2024, 44(4): 954-968.
[11] Patel MS, Miranda-Nieves D, Chen J, et al. Targeting p-selectin glycoprotein ligand-1/p-selectin interactions as a novel therapy for metabolic syndrome [J]. Transl Res, 2017, 183: 1-13.
[12] Belouin A, Simard RD, Joyal M. Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P-selectin binding sites [J]. Bioorg Med Chem, 2024, 98: 117553.
[13] Takada YK, Simon SI, Takada Y. The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand [J]. Life Sci Alliance, 2023, 6(7): e202201747.
[14] Liu G, Liang B, Song X, et al. P-selectin increases angiotensin II-induced cardiac inflammation and fibrosis via platelet activation [J]. Mol Med Rep, 2016, 13(6): 5021-5028.
[15] Piqueras L, Kubes P, Alvarez A, et al. Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT1 and AT2 receptor-mediated p-selectin upregulation [J]. Circulation, 2000, 102(17): 2118-2123.
[16] Romuk E, Skrzep-Poloczek B, Wojciechowska C, et al. Selectin-P and interleukin-8 plasma levels in coronary heart disease patients [J]. Eur J Clin Invest, 2002, 32(9): 657-661.
[17] Qiu BS, Cai XL, Wang YJ, et al. Association of serum thromboinflammatory biomarkers with atherosclerotic plaques and burden in a community-based population [J]. Arterioscler Thromb Vasc Biol, 2025, 45(9): 1672-1682.
[18] Zingarelli B, Salzman AL, Szabó C. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury [J]. Circ Res, 1998, 83(1): 85-94.
[19] Zhang K, Li R, Chen XN, et al. Renal endothelial cell-targeted extracellular vesicles protect the kidney from ischemic injury [J]. Adv Sci (Weinh), 2022, 10(3): e2204626.
[20] Yan H, Mi X, Midgley AC, et al. Targeted repair of vascular injury by adipose-derived stem cells modified with p-selectin binding peptide [J]. Adv Sci (Weinh), 2020, 7(11): 1903516.

基金

河南省医学科技攻关计划省部共建项目(SBGJ202303050);郑州市医疗卫生领域科技创新指导计划项目(2025YLZDJH129);郑州市科技创新指导计划项目(2025YLZDJH139);郑州市中青年人才国际化培养项目(ZZGJH2024007)

PDF(1257 KB)

Accesses

Citation

Detail

段落导航
相关文章

/